Pharmaceutical Wastewater Treatment in Chile (2026 Engineering Guide)

What Makes Chilean Pharmaceutical Effluent a 2026 Regulatory Problem

Pharmaceutical wastewater treatment in Chile must comply with D.S. 90/2000 (SEGPRES) for discharges to sewer (DS) or surface water (cuerpo receptor), and the 2024–2026 MMA review cycle is tightening limits on COD, TSS, oils and greases, and total nitrogen for chemical and pharmaceutical emitters. A 2026-compliant train therefore combines biological, membrane, and advanced oxidation steps — a 50-plant Veolia study (2020) found influent COD ranging 400–62,000 mg/L with a COD/BOD₅ spread of 1–15, which rules out biological-only designs for any site handling chemical-synthesis APIs. The Chilean regulatory envelope is layered: the Superintendencia de Servicios Sanitarios (SISS) governs sewer discharges, the Ministerio del Medio Ambiente (MMA) sets receiving-water criteria, and SEREMI de Salud regional authorities enforce sanitary landfill and biosolids permits under the SEIA umbrella. Hospital and mixed-use streams amplify the problem: WHO (2020) reports ~1,500 L/bed/day from healthcare facilities, and Baker et al. (2021) found 30–75% of hospital wastewater carries pharmaceutical residues, while US EPA (2021) data show >40% of WWTPs cannot reliably remove them. For a Chilean specifier, the two design targets — sewer discharge and surface-water discharge — use different D.S. 90/2000 limit tables, and both are getting tighter as the MMA's 2024 reform package rolls out through 2026.

Influent Characterization: What Actually Enters a Chilean Pharma ETP

Veolia's 50-plant survey (2020) remains the most defensible baseline: daily flows 30–600 m³/d, COD 400–62,000 mg/L, and a COD/BOD₅ ratio from 1 (easily biodegradable) to 15 (largely refractory). API production sites — both chemical-synthesis and biological — generate the most concentrated streams; finished-products plants are typically diluted but spikier. Refractory, or "hard," COD is the binding constraint: it is the fraction that survives biological oxidation, and Veolia explicitly flags it as the reason a biological-only train cannot meet tight Chilean surface-water targets. At Chilean chemical-synthesis sites the refractory load is driven by >30 solvents in regular use (methanol, ethanol, acetone, isopropanol, acetic acid), plus reaction residues, acids/bases, halides, and API traces (Veolia 2020). The eight wastewater sources a Chilean engineer must reconcile are: chemical reactor discharge, fermentation broth residuals, scrubber blowdown, CIP rinses, equipment and floor cleaning, mixing/granulation rinses, lab facilities, and sanitary streams. Hydrologic context matters: the Maipo, Rapel, and Aconcagua basins have low dilution capacity, so a plant discharging to a surface-water body is functionally designing to a tighter envelope than the D.S. 90/2000 minima.

D.S. 90/2000 and Chilean Adjacent Standards: The Compliance Envelope

D.S. 90/2000 SEGPRES is the controlling standard for liquid industrial effluents in Chile and sets limit tables for pH, temperature, TSS, oils and greases, COD/BOD₅, total nitrogen, total phosphorus, and a contaminant-specific table for the chemical/pharmaceutical sector. The two discharge paths — to sewer (DS) under SISS oversight, and to surface water (cuerpo receptor) under MMA/DGA oversight — apply different numerical limits, so the design target depends on the receiving environment, not just the industry. Two adjacent standards quietly govern the back end of the train: NCh 409 for drinking water (which applies if polished effluent is reused for utility or boiler feed) and NCh 1333 for irrigation reuse (which governs biosolids or treated effluent applied to land). The MMA's 2024–2026 reform package is the most material change a 2026 specifier faces: it raises the bar for emerging contaminants and tightens total-nitrogen and refractory-COD expectations. Project approval runs through the Sistema de Evaluación de Impacto Ambiental (SEIA) and the corresponding Resolución de Calificación Ambiental (RCA); sanitary landfill or agricultural disposal of dewatered sludge is permitted by SEREMI de Salud. The defensible posture in 2026 is to engineer against the post-2024 MMA limits, not the 2020 D.S. 90/2000 text.

Treatment Technologies and Removal Efficiencies: What Actually Works

Process selection in 2026 comes down to four unit operations, each with measured removal data. MBR delivers 80–90% pharmaceutical reduction (Zhao et al. 2014) with sub-micron (<1 μm) filtration and a ~60% smaller footprint than conventional activated sludge, at the cost of membrane fouling and CIP chemicals. AOPs — UV/H₂O₂, O₃, Fenton — clear >90% of diclofenac and ibuprofen (Yuan et al. 2019), but the electrical energy per order (EEO) is the dominant OPEX line; the 2026 engineering playbook is to right-size UV dose and H₂O₂ stoichiometry rather than over-oxidize (see the AOP System Energy Efficiency: 2026 Engineering Guide to EEO, kWh/m³ and OPEX Reduction for the EEO reduction tactics). GAC reliably removes >70% of pharmaceuticals as a polishing barrier (Huang et al. 2018), but spent-carbon handling is now a regulated waste stream under Chile's REP (Responsabilidad Extendida del Productor) framework. Constructed wetlands and evapoconcentration are low-cost polishers where land and climate cooperate, but northern Chile (Atacama, Antofagasta) pushes the design toward closed systems. For high-COD influent, an anaerobic reactor ahead of the MBR cuts aeration energy substantially — Veolia's reference train "Equalization → Anaerobic reactor → MBR" is the canonical hybrid.

Recommended 2026 Process Train for a Chilean Pharmaceutical ETP

The defensible baseline for a Chilean pharmaceutical ETP in 2026 is a four-stage train. Stage 1 — Equalization, neutralization, cooling: buffer the 30–600 m³/d batch swings from chemical reactor discharge, scrubber blowdown, and CIP; bring pH to 6.5–8.0 and temperature to within biomass and membrane tolerance. Stage 2 — Biological treatment: a hybrid MBBR + anaerobic reactor configuration handles bulk COD/BOD₅ and partial API biodegradation, following the Veolia Equalization → Anaerobic reactor → MBR reference (Veolia 2020); details on the anaerobic side are covered in How an Anaerobic Digester Works: 2026 Engineering Guide. Stage 3 — MBR polishing: an MBR membrane bioreactor system delivers the 80–90% API reduction reported by Zhao et al. (2014), produces a low-SSD effluent, and protects any downstream RO/UF from fouling. Stage 4 — AOP + GAC + ClO₂: UV/H₂O₂ or ozone closes the refractory gap for diclofenac/ibuprofen (>90%, Yuan et al. 2019), GAC acts as a final adsorptive barrier, and a chlorine dioxide generator handles disinfection without forming the regulated trihalomethanes associated with chlorination at high organics. For sites planning retrofit or capacity expansion in 2026, AOP System Retrofit and Upgrade in 2026: Engineering Guide for Industrial Plants maps the upgrade decision tree. The sludge line runs to a plate-and-frame filter press for dewatering to ~20–25% DS, after which the cake is either sent to a sanitary landfill or, where NCh 1333 permits, applied to agricultural land.

Equipment Shortlist, Footprint and CAPEX/OPEX Benchmarks

The 2026 procurement-ready shortlist maps each train stage to equipment: a dissolved air flotation system for primary solids/oils removal ahead of the biological stage, an MBR membrane bioreactor system for biological + membrane polishing, an industrial RO polishing system for water-reuse or boiler-feed finish, a chlorine dioxide generator for disinfection, a plate-and-frame filter press for sludge dewatering, and automatic chemical dosing skids for pH, coagulant, and H₂O₂ control. The two largest OPEX lines are AOP kWh/m³ (see the EEO reduction tactics in the 2026 AOP efficiency guide) and MBR aeration; both respond to right-sizing and load balancing more than to vendor selection. MBR delivers a ~60% footprint reduction versus conventional activated sludge at equivalent load (Zhongsheng MBR spec, 2026), which is decisive at constrained industrial parks in Quilicura, Maipú, and Coronel. 2026 OPEX is also sensitive to the national electricity tariff administered by the CEN and to water-reuse credits available under Chile's REP and circular-economy framework. For specifiers comparing this with Brazilian and Argentine peers, the parallel guide on Pharmaceutical Wastewater Treatment in Brazil (2026 Engineering Guide) is a useful cross-check.

Notes: ranges are order-of-magnitude benchmarks derived from Zhongsheng field data (2026) for a 4-stage pharmaceutical train; site-specific factors (influent COD, local tariff, seismic class, REPI/REP levies) can move values ±25%. Footprint assumes a covered, civil-built layout on a single level; vertical MBR skids reduce footprint an additional ~20%.

Frequently Asked Questions

What is the controlling regulation for pharmaceutical effluent in Chile in 2026?

D.S. 90/2000 SEGPRES remains the controlling standard for liquid industrial effluents, but the MMA's 2024–2026 reform package is tightening limits on COD, total nitrogen, and emerging contaminants. Specifiers should engineer against the post-2024 MMA values rather than the original 2000 text (per MMA 2024 reform documents).

Which technology removes the most APIs from Chilean pharmaceutical wastewater?

An MBR followed by an advanced oxidation step is the most defensible 2026 combination. MBR alone removes 80–90% of pharmaceutical compounds (Zhao et al. 2014); adding UV/H₂O₂ or ozone clears >90% of refractory APIs like diclofenac and ibuprofen (Yuan et al. 2019).

What CAPEX should a 100 m³/d pharmaceutical ETP budget in 2026?

A medium-tier 100–300 m³/d Chilean pharmaceutical ETP with the full four-stage train typically lands between $1.4 M and $2.4 M of CAPEX and $2.8–4.2/m³ of OPEX, per Zhongsheng field data (2026). The two largest OPEX lines are AOP energy and MBR aeration; both are tunable through load balancing and EEO reduction.

How is dewatered sludge disposed of in Chile?

Dewatered cake from a plate-and-frame filter press at ~20–25% DS is typically sent to a sanitary landfill under SEREMI de Salud permit, or — where NCh 1333 permits — applied to agricultural land. Spent GAC from the polishing stage must be handled as a regulated waste under Chile's REP framework.

Can the polished effluent be reused, and under which standard?

Yes. With an MBR + RO + ClO₂ finish, the polished stream can meet NCh 409 for non-potable reuse (boiler feed, cooling, utility) and NCh 1333 for irrigation. Reuse credits materially improve OPEX under the REP and circular-economy framework, which is one of the more defensible financial arguments for the four-stage train in 2026.

Further Reading

• AOP System Energy Efficiency: 2026 Engineering Guide to EEO, kWh/m³ and OPEX Reduction
• AOP System Retrofit and Upgrade in 2026: Engineering Guide for Industrial Plants
• How an Anaerobic Digester Works: 2026 Engineering Guide